MY8500456A - A crystalline salt of a cephacosporin derivative - Google Patents

A crystalline salt of a cephacosporin derivative

Info

Publication number
MY8500456A
MY8500456A MY456/85A MY8500456A MY8500456A MY 8500456 A MY8500456 A MY 8500456A MY 456/85 A MY456/85 A MY 456/85A MY 8500456 A MY8500456 A MY 8500456A MY 8500456 A MY8500456 A MY 8500456A
Authority
MY
Malaysia
Prior art keywords
cephacosporin
derivative
crystalline salt
crystalline
salt
Prior art date
Application number
MY456/85A
Other languages
English (en)
Inventor
Hideaki Natsugari
Iwao Mikami
Michihiko Ochiai
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of MY8500456A publication Critical patent/MY8500456A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MY456/85A 1978-12-11 1985-12-30 A crystalline salt of a cephacosporin derivative MY8500456A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15337778A JPS5579393A (en) 1978-12-11 1978-12-11 Cephalosporin derivative and its preparation

Publications (1)

Publication Number Publication Date
MY8500456A true MY8500456A (en) 1985-12-31

Family

ID=15561123

Family Applications (1)

Application Number Title Priority Date Filing Date
MY456/85A MY8500456A (en) 1978-12-11 1985-12-30 A crystalline salt of a cephacosporin derivative

Country Status (18)

Country Link
US (1) US4298607A (de)
JP (1) JPS5579393A (de)
BE (1) BE880518A (de)
CA (1) CA1128499A (de)
CH (1) CH646437A5 (de)
DE (1) DE2949485A1 (de)
DK (1) DK159785C (de)
ES (1) ES8100299A1 (de)
FR (1) FR2444042A1 (de)
GB (1) GB2036746B (de)
GR (1) GR74078B (de)
HK (1) HK9486A (de)
IT (1) IT1126514B (de)
MY (1) MY8500456A (de)
NL (1) NL190487C (de)
NO (1) NO158219C (de)
SE (1) SE447117B (de)
SG (1) SG93185G (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78221B (de) * 1980-02-01 1984-09-26 Ciba Geigy Ag
US4400503A (en) * 1981-10-30 1983-08-23 Eli Lilly And Company Purification of syn-7-[[(2-amino-4-thiazolyl)(methoxyimino) acetyl]amino]-3-methyl-3-cephem-4-carboxylic acid
US4594417A (en) * 1981-10-30 1986-06-10 Eli Lilly Company Crystalline antibiotic salt
US4902683A (en) * 1984-10-25 1990-02-20 The Upjohn Company Crystalline cephalosporin hydrohalide salts
EP0638573A1 (de) * 1993-08-10 1995-02-15 Lucky Ltd. Kristalline Hydrate eines Cephalosporins und Verfahren zu ihrer Herstellung
ATE440101T1 (de) 2003-03-27 2009-09-15 Basilea Pharmaceutica Ag Cephalosporin in kristalliner form

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
FR2345153A1 (fr) * 1976-03-25 1977-10-21 Roussel Uclaf Nouvelles alcoyloximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
GB1576625A (en) * 1976-04-12 1980-10-08 Fujisawa Pharmaceutical Co Syn isomer 3,7 disubstituted 3 cephem 4 carboxylic acid compounds and processes for the preparation thereof
JPS603314B2 (ja) * 1976-08-31 1985-01-26 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
BE880518A (fr) 1980-06-10
NO158219C (no) 1988-08-03
ES486680A0 (es) 1980-11-01
GB2036746B (en) 1983-02-09
SG93185G (en) 1987-03-27
NO793989L (no) 1980-06-12
NL7908869A (nl) 1980-06-13
DK524579A (da) 1980-06-12
GR74078B (de) 1984-06-06
DK159785B (da) 1990-12-03
DE2949485A1 (de) 1980-06-19
SE7909998L (sv) 1980-06-12
US4298607A (en) 1981-11-03
SE447117B (sv) 1986-10-27
DE2949485C2 (de) 1989-06-08
FR2444042A1 (fr) 1980-07-11
NL190487B (nl) 1993-10-18
ES8100299A1 (es) 1980-11-01
CA1128499A (en) 1982-07-27
GB2036746A (en) 1980-07-02
IT1126514B (it) 1986-05-21
CH646437A5 (de) 1984-11-30
NL190487C (nl) 1994-03-16
NO158219B (no) 1988-04-25
JPS5579393A (en) 1980-06-14
FR2444042B1 (de) 1983-06-24
JPS636552B2 (de) 1988-02-10
HK9486A (en) 1986-02-14
DK159785C (da) 1991-04-22
IT7927924A0 (it) 1979-12-07

Similar Documents

Publication Publication Date Title
EG12663A (en) Preparation of a new vincamine salt
IL56296A0 (en) The preparation of a 4-naphthyl-butan-2-one derivative
IL51956A (en) Crystalline form of l-lysine salt of cefuroxime
JPS5585416A (en) Semicontimuous manufacture of zeolite a
JPS5517388A (en) Inorganic salt of polyenemachloridee trimethylammonium derivative
MY8500456A (en) A crystalline salt of a cephacosporin derivative
JPS5678564A (en) Removal of pottasium salt
DE2963413D1 (en) Process for the preparation of a hydroxylamine salt
JPS5513293A (en) Derivative of nntrifluoloacetyllnnphosphono methylglycinate
GB2034305B (en) Preparation of piperidine derivatives
ZA767330B (en) A crystalline sodium salt
EG14105A (en) A process for the preparation of aurone derivatives
IL58678A0 (en) Preparation of a salt of 3,3-dimethyl-2-oxo-butyric acid
JPS54163591A (en) Manufacture of crystalline cephalosporin derivative
EG14314A (en) A process for the preparation of heterocyclic compounds
GB1540783A (en) Crystalline potassium salt of beta-nicotinamide-adenine-dinucleotide-phosphoric acid
ZA791504B (en) A penicillin salt
DE3379402D1 (en) A crystalline prostaglandin salt
GB2048103B (en) Stabilisation of hygroscopic salts
PT66991B (en) Preparation process of a new pyrimidine derivative
JPS54115396A (en) 22dithienylmethylene quinolitidine quaternary salt derivative
JPS5524169A (en) 55iodoo33nitroo44hydroxybenzonitrile salt
ZA79305B (en) Prostaglandin derivatives
JPS53145964A (en) Production of salt for tempra
AU77585S (en) a combined salt & peppermill